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Abstract
Because of the numerous entities interacting, the complexity of the networks that regu-
late cell fate makes it impossible to analyze and understand them using the human brain 
alone. Computational modeling is a powerful method to unravel complex systems. We 
recently described the development of a user-friendly computational tool, Analysis of 
Networks with Interactive MOdeling (ANIMO). ANIMO is a powerful tool to formalize 
knowledge on molecular interactions. This formalization entails giving a precise math-
ematical (formal) description of molecular states and of interactions between molecules. 
Such a model can be simulated, thereby in silico mimicking the processes that take place 
in the cell. In sharp contrast to classical graphical representations of molecular interac-
tion networks, formal models allow in silico experiments and functional analysis of the 
dynamic behavior of the network. In addition, ANIMO was developed specifically for 
use by biologists who have little or no prior modeling experience. In this chapter, we 
guide the reader through the ANIMO workflow using osteoarthritis (OA) as a case study. 
WNT, IL-1β, and BMP signaling and cross talk are used as a concrete and illustrative 
model.
Keywords: WNT, IL1β, BMP, cartilage, computational model, ANIMO, cell signaling, 
network modeling
1. Introduction
1.1. Signal transduction networks
At any given point in time, cells are exposed to many different signals from their environ-
ment. Cells will have to interpret this multitude of signals they receive. Signal transduction 
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networks relay and integrate signals from membrane-bound receptors, via protein activation, 
to the nucleus in order to regulate cellular processes such as gene transcription, metabolism, 
proliferation, differentiation, and apoptosis (programmed cell death).
Kinases play a key role in signal transduction by transferring phosphate groups to their 
substrates in a process called phosphorylation [1–4]. In this context, phosphorylation is basi-
cally a way to hand over a signal. In practice, kinases function by phosphorylating serine, 
threonine, or tyrosine residues on downstream substrates, thereby inducing conformational 
changes and/or charge alterations, resulting in modulation of protein activities [5].
Signal transduction pathways are connected to other signal transduction pathways in a mecha-
nism we call cross talk. Due to this cross talk, signaling pathways are part of extensive signaling 
networks. Ultimately, dynamic changes in the signaling network determine cell fate. Insight 
into this network-regulating cell fate is important for controlling stem cell differentiation, under-
standing diseases such as cancer and osteoarthritis (OA), defining better diagnostics based on 
biomarker expression, and designing precision therapies.
1.2. Network topology and dynamics
To understand signaling networks, graphical representations are very useful (and widely 
used). In such graphical network representations, network topology and protein interactions 
are displayed in a static way. This is very useful for understanding network topology but 
fails to show the dynamics of the network interactions. In addition, as networks become large 
with many interactions between signaling molecules, it becomes harder to comprehend and 
predict the speed of the network interactions. Since we want to understand the dynamics of 
signaling networks, we need to incorporate quantitative aspects like activity levels and the 
timing of interactions. Understanding the interplay between the quantitative dynamics and 
the distributed and concurrent nature of networks with large numbers of components is a for-
midable task; this task can only be successfully undertaken by using methods and techniques 
that are adequately supported by software tools.
1.3. Computational modeling of signaling networks
The systems biology approach to understanding biological systems starts off from a scien-
tific question and then follows an empirical cycle—or rather a positive spiral—of knowledge/
theory → model → hypotheses → experiments → observations → update and/or refinement 
of knowledge/theory, until an answer to the original question is found (Figure 1). The model 
plays a pivotal role in this cycle:
1. To organize data and store knowledge
2. To structure reasoning and discussion
3. To perform in silico experiments and derive hypotheses
An in silico model is always a simplified representation of biological reality and is never the 
aim in itself. Rather, it is a powerful means in the process of gaining an understanding of the 
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biological system. Given its role in the empirical cycle, the process of modeling is especially 
effective when applied by the experts with respect to a certain biological system. Biologists 
usually have a good sense of cause-and-effect relationships of molecular interactions. In 
addition, they are the most knowledgeable on the network topology and the dynamics of 
the biological system they are studying. Since they also benefit most from the generation of 
hypotheses and from an efficient experimental design, biologists would be the primary can-
didates to construct models of their research topic.
As models are a formalization of knowledge or theories, an underlying formalism is needed 
to express this knowledge. Different formal methods have been successfully applied to con-
struct representations of biological systems. Among these methods are Boolean logic [6, 7], 
ordinary differential equations (ODEs, reviewed in Ref. [8]), interacting state machines [9, 10], 
process calculi [11, 12], timed automata [13–15], and Petri nets [16, 17]. Most of these formal 
methods have been implemented into software tools to aid the process of modeling.
Mastery of most existing modeling tools requires training and experience in mathematical 
modeling. In this respect, a lack of tradition in quantitative reasoning and formal methods 
within the biological community at large is still a stumbling block for widespread applica-
tion of modeling of biological systems. To overcome this, we built an intuitive method for the 
construction of formal in silico models of the dynamics of molecular networks, supported by a 
user-friendly modeling tool, (Analysis of Networks with Interactive MOdeling (ANIMO) [18]).
1.4. ANIMO
ANIMO is an activity network tool, built as a plug-in to the network visualization program 
Cytoscape [19] and founded on the formalism of timed automata [13–15], but does not require 
Figure 1. The empirical spiral: applying the empirical cycle in successive rounds leads to a gradual buildup of knowledge.
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the user to have any previous training in formal methods [20]. This provides the advantages 
of formal models (in silico experiments and model checking) without renouncing to usability.
Nodes in an ANIMO network represent an activity level of any given biological entity, e.g., 
proteins directly involved in signal transduction (e.g., kinases, growth factors, cytokines, 
genes, and mRNA. An activity level is associated to each node, to represent, for example, the 
relative amount of phosphorylated kinase or the concentration of mRNA. The activity level of 
a node can be altered by interactions with other nodes. ANIMO networks can include activa-
tions (→) and inhibitions (─┤), which will increase (resp. decrease) the activity level of the 
target node if the source node is active. For example, A → B will increase the activity level of 
B if A is active. The speed at which an interaction occurs is defined by its k parameter, which 
can be estimated qualitatively by choosing among a predefined set of options (very slow, slow, 
medium, fast and very fast) or by directly inputting a numerical value. We note that using the 
qualitative choices already leads to useful models: choosing, for example, a slow interaction 
to represents the production of a protein, and a fast one for a posttranslational modification 
such as phosphorylation is already enough to provide a realistic behavior in a network with 
the proper node topology [18, 20, 21].
A finer control on the network dynamics can be obtained by choosing for each interaction an 
approximated scenario which allows to describe the interaction. A choice is available among 
three scenarios:
• Scenario 1 (default): the interaction rate is linearly dependent on the k parameter and the 
activity level of the upstream node. This is the simplest scenario and is advised for all inter-
actions when first building an ANIMO model.
• Scenario 2: the interaction rate depends on the k parameter and on the activity levels of 
both nodes. In particular, it is linearly dependent on the activity level of the upstream node 
and inversely dependent on the activity of the downstream node. This scenario is used to 
model reactions where the availability of substrate is a limiting factor.
• Scenario 3 (AND gate): the interaction rate depends on the k parameter and on the activ-
ity level of two user-defined nodes. The user can determine whether the dependency on 
a node’s activity is linear or inverse. This scenario can be used to represent Boolean AND 
gates, such as “A AND B → C,” where it is required that both A and B are active in order 
for C to become active.
Additionally, the k parameter can be manually set to numerical values, expanding the default 
qualitative choices. Methods for parameter fitting are also present in ANIMO, which allow to 
automatically adapt the parameters to a given data set [22]. These features are useful when 
comparing a model to experimental data and allow to easily try different parameter settings 
before needing to extend a model with new nodes or interactions.
1.5. Experimental requirements
Biological events can often be interpreted as changes in activity. Activities could be defined 
as changes in concentration, phosphorylation, or localization of a protein or changes in gene 
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expression because they are causal factors with respect to downstream effects. Therefore, the 
state or concentration of the molecules can be described in terms of an activity. The more 
active the molecule is, the stronger it will affect downstream processes.
Experimental design could be performed according to these guidelines:
1. A negative control (t = 0) is needed to determine background activity levels.
2. Including a positive control for each of the measurements indicates the potential maxi-
mum intensity in the biological system. This allows scaling of activity between 0 and 
100% to construct a nondimensional model, omitting the need for precise intracellular 
concentrations.
3. Include measurements of molecules that either have downstream effects in the model or 
can be used as an output of the model.
4. Include overlapping treatment conditions to normalize experimental data between differ-
ent days or assay batches.
5. Include multiple time points to provide insight into the dynamic behavior of the system. 
To decide how many time points should be measured and what the optimum time range 
is, consider the following factors. Ideally, measurements are obtained at time points start-
ing from t = 0 until the system reaches a steady state. For most primary effects in signal 
transduction networks, this means measuring more time points in the first 2–30 minutes 
after stimulation. When peak dynamics are expected, three time points are the absolute 
minimum to describe each peak, one before the peak, one as close as possible to the actual 
peak, and one after the peak. Five time points and more allow finding and describing a 
peak in more detail, especially in the presence of experimental noise. If no peak dynamics 
are expected, at least four time points should be measured. Try to avoid having the highest 
measurement value as the first or last value in your time series, as it will lead to uncertainty 
about the actual behavior of the system.
We can discern primary (or direct) effects or higher order (or indirect) effects after treatment. 
Indirect effects are those in which feedback is involved. For signal transduction, the primary 
effect occurs in time points up to 240/480 minutes. For gene expression, primary effects typi-
cally take 4–12 hours. Higher order effects occur at different time ranges, e.g., signal trans-
duction could occur up to 24/48 hours; for gene expression involving higher order effects, for 
example, in the case of cell differentiation, effects can take up to several weeks.
2. Case study: ANIMO modeling of inflammatory signals 
in  osteoarthritis
Many diseases are multifactorial, affected by many factors including genetic predisposition, 
age, trauma, sex, etc. These factors influence the network topology as well as its dynamics. 
This is hard to capture in static networks. To guide the reader through the ANIMO workflow, 
we use osteoarthritis as a case study.
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Osteoarthritis (OA) is a painful, disabling disease with a high prevalence, occurring in about 
15% of the population. The lifetime risk of knee OA is over 40% for man and almost 50% for 
women (reviewed in Ref. [23]). The lack of insight into the intricate signaling network of the 
cartilage has prevented the identification of highly needed disease-modifying osteoarthritic 
drugs (DMOADs). We aim to solve this by generating a comprehensive computational model 
of the signaling network in the cartilage [24]. In this chapter, we describe three important 
pathways in cartilage and OA development as a case study.
2.1. Osteoarthritis
Articular cartilage (AC) is a highly resilient tissue that covers the surfaces at the ends of long 
bones and ensures the pain-free and supple movement of our joints. The cartilage is mainly 
composed of one single cell type, the chondrocyte, which secretes and shapes the cartilagi-
nous matrix that is necessary for its load-bearing properties. The biomechanical properties of 
the cartilage are dependent mainly on the composition, as well as the integrity of its matrix 
[25]. Once damaged, articular cartilage has low self-repair and regenerative capabilities even-
tually resulting in OA. This is due to its avascular nature, lack of innervation, and the embed-
ding of chondrocytes in a dense matrix preventing cell migration. In addition, abnormalities 
in the cartilage-specific matrix cause a variety of skeletal malformation syndromes as well as 
adult-onset degenerative disorders such as OA.
OA is the most common form of arthritis and a leading cause of mobility-associated disability. 
OA is characterized by degeneration of articular cartilage, typical bone changes, and signs 
of inflammation, particularly in end-stage disease. The current management of OA is symp-
tomatic, aimed at reduction of pain and at the end stage of disease total joint replacement 
as a successful treatment option for large joints (e.g., knee and hip) [26]. These treatments, 
however, do not cure the disease. There are no systemic drugs that can modify the disease 
process. Once the cartilage is damaged, no treatment exists that can intervene effectively, and 
the affected joint enters a disease continuum toward osteoarthritis.
Cartilage tissue homeostasis depends on a fine balance between catabolic (breakdown) and 
anabolic (buildup) processes. Homeostasis is regulated by a number of signaling pathways, 
including BMP and WNT signaling [27–31]. The amplitude of the signaling can be fine-tuned 
via antagonists in the extracellular space (reviewed in Ref. [32]). Typical catabolic pathways 
include the inflammatory pathways, including TNFα and IL-1β.
2.2. Osteoarthritis at the molecular level
OA is a disease caused by loss of homeostasis, resulting in altered mechanical and biochemi-
cal signals. Some of the key biochemical signals are growth factors such as WNT, IL-1β, trans-
forming growth factor beta, bone morphogenetic proteins (BMPs), and Indian hedgehog 
homolog [27, 33, 34]. Mechanical stress on the extracellular matrix (ECM) plays a key role in 
OA development [27, 33, 34]. Any changes in this complex biological system, such as those 
caused by injury or aging, can disrupt cartilage homeostasis and lead to either catabolism 
characterized by expression of, for example, matrix metalloproteases (MMPs), and aggreca-
nases (ADAMs), or anabolism characterized by expression of collagen II and aggrecans [33]. 
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As OA progresses the chondrocytes start to lose their characteristic phenotype, which in some 
cases results in differentiating into hypertrophic chondrocytes [35], resulting in endochon-
dral ossification, by destroying the surrounding collagen II and replacing it with collagen X. 
Eventually, the hypertrophic chondrocytes will recruit osteoblasts that will proceed to form 
an osteophyte [35]. It is important to note that OA is not a disease that will damage the whole 
joint evenly. Throughout the cartilage there will be cells in different stages of differentiation, 
ranging from seemingly healthy cells to osteophyte forming hypertrophic chondrocytes.
The direct control of chondrogenic differentiation and hypertrophy is believed to be tightly 
regulated by the transcriptional activity of two main transcription factors: RUNX2, a tran-
scription factor important for the regulation of hypertrophic differentiation, and SOX9, mas-
ter transcription factor for chondrogenic development [36, 37]. The exact activity of these 
factors seems a key in determining the outcome of the chondrocyte phenotype.
The first steps in any computational modeling workflow are to thoroughly investigate the 
signal transduction pathways involved in the disease and to choose which pathways will 
be focused on. In this example, we will show the BMP and WNT signaling pathways for 
their importance in cartilage development and IL-1β as an inflammatory signal involved in 
osteoarthritis.
2.2.1. WNT signaling in the cartilage and osteoarthritis
The canonical Wnt pathway is crucial for cell survival and OA activation. The canonical path-
way is characterized by the axin/glycogen synthase kinase-3β (GSK3-β) destruction complex 
which maintains low intracellular concentration of the key transcriptional regulator, β-catenin 
[33]. WNTs bind to the Frizzled (Fz) transmembrane receptors, resulting in the recruitment 
of the transmembrane protein LRP5/6. This complexation leads to the phosphorylation and 
dissociation of the destruction complex allowing β-catenin to accumulate and translocate to 
the nucleus [33]. In turn, β-catenin downregulates both collagen type 2A (COL2A) and SRY-
box 9 (SOX9), leading to cell dedifferentiation and proliferation [38]. The WNT pathway can 
be activated by IL-1β through the phosphoinositide 3-kinase (PI3K) – protein kinase B (Akt) 
pathway [39, 40].
2.2.2. BMP2 signaling in osteoarthritis
BMP2 signaling is key pathway in the development of both the bone and cartilage. In endo-
chondral bone formation, it is responsible for the clustering of the mesenchymal stem cells, 
the acquisition of the chondrocyte phenotype, and the final differentiation into hypertro-
phic chondrocytes [41, 42]. This final step is stopped in order to produce adult chondro-
cytes [41]. BMP2 is found in both healthy and OA adult chondrocytes [42]. BMP2 signaling 
occurs when BMP2 binds to its type 1 and type 2 receptors, which in turn phosphorylate 
mothers against decapentaplegic (SMAD) homologs 1, 5, and 8. Subsequently, SMAD 1, 5, 
or 8 dimers could bind to the ubiquitous SMAD-4 transcription factor [41]. BMP2 signal-
ing can upregulate Col2a, SOX9, ColX, and MMP13 gene expression [38, 41]. Once OA is 
advanced, BMP2 can cause hypertrophic differentiation of chondrocytes, leading to osteo-
phyte formation [41].
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2.2.3. Interleukin 1β signaling in osteoarthritis
IL-1β is a key pro-inflammatory cytokine that drives OA progression by inducing the expres-
sion of cartilage degrading enzymes such as matrix metalloproteinases (MMPs) [43, 44].
IL-1β signals by binding to the transmembrane IL-1 receptor I (IL-1RI), leading to the activa-
tion of multiple signaling pathways. The canonical IL-1β pathway signals through NF-κB, 
but IL-1β can also activate the p38-MAPK and JNK-MAPK pathways. The activated recep-
tor then assembles two signaling proteins, myeloid differentiation primary response gene 
88 (MYD88) and interleukin-1 receptor-activated protein kinase 4 (IRAK4). Together, the 
proteins form a stable IL-1-induced first signaling module and activate IRAK1 and IRAK2, 
which in turn activate TRAF6, PELI 1-3, TAK1, and MEKK3 [45]. IRAK1 also activates the 
inhibitor of nuclear factor B kinase (IKK) complex, which is necessary for the translocation of 
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) subunits to the core. 
The IKK complex consists out of IKK1 and IKK2 plus the regulatory subunit NF-κB essential 
modifier (NEMO) and phosphorylates IkB, the inhibitor of NF-κB, leading to its degradation 
[45, 46]. Due to the degradation of IkB, two NF-κB subunits, p50 and p65, are released and 
translocate into the nucleus, where they bind to conserved DNA motifs, which exist in many 
IL-1β responsive genes, including the genes for IL-1B [45, 46] and IκBα [45].
For the p38 MAPK and the JNK pathways, TAK1 and MEKK3 are mainly responsible, which 
activate MAPK kinase kinases (MKKs) 3, 4, 6, and 7 [45]. In addition, ERK1/ERK2 is also 
activated as a result of the activation of the IKK complex, which influences MKK1. All three 
MAPK pathways influence the activation protein 1 (AP-1), affecting the DNA expression of 
IL-1β response genes [45].
An increasing amount of data indicates the influence of IL-1β on the degeneration of extracel-
lular matrix in the pathology of OA [47]. In addition, we have previously shown that WNT/β-
catenin inhibits IL-1β-induced MMP expression in human articular cartilage [48]. Moreover, 
we showed that the WNT/β-catenin-regulated transcription factor TCF4 can bind to NF-κB, 
thereby enhancing NF-κB activity [30].
2.3. Defining an a priori network
The aim of computational modeling is not to provide the most complete representation of all 
the interactions in a signaling network, but to use as many interactions as needed to provide 
insight into cellular mechanisms. As such, models are indeed simplified representations of the 
real situation: one can choose a level of abstraction depending on the available information 
and the research question that is asked. The level of abstraction is always a trade-off between 
precision and feasibility.
In the case study presented here, we do not aim to build a precise model, but aim to show how 
building a model enables researchers of all levels of experience to visualize, summarize, and 
formalize models. Generating a relatively simple model in which key interactions are shown 
enables researchers to test and discuss various hypotheses quickly. With the obtained insight, 
one can then choose to validate only those hypotheses that the researchers will expect to truly 
yield new information. The model is then used as a backbone for the smart design of wet lab 
experiments rather than the trial-and-error methods that are traditionally used in the field.
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2.3.1. Defining a research question
We base our research question on our analysis of the role of the individual pathways and their 
possible cross talk on OA development. Although the roles of WNT and BMP in cartilage and 
OA development are well described, the precise interactions between WNT, BMP, and IL-1β in 
regulating OA and chondrocyte hypertrophy are not fully understood (reviewed in Ref. [31]).
The model can be used for rapid and reiterative queries to derive and probe hypotheses such as 
whether IL-1β could influence cartilage homeostasis by modulating the activity of the cartilage 
and bone transcription factors SOX9 and RUNX2 and their downstream targets. Similarly, the 
role of BMP and WNT signalings, two important pathways in cartilage development and main-
tenance, can be explored on their potential modulatory roles on IL-1β expression and function.
To explore this example and provide a concrete guide through the ANIMO workflow, we will 
first draw a priori knowledge network, then formalize this network based on literature and 
our own data, and then perform a few simple in silico experiments that will be validated in 
the wet lab.
2.3.2. Drawing a priori knowledge network
To build an a priori network, we use KEGG (www.genome.jp/kegg) and WikiPathways 
(wikipathways.org) to decide on the topology of the proteins in the network.
We first draw an a priori network diagram that includes some of the most important factors 
in the signaling pathways of interest: IL-1β (based on: WikiPathways WP2637), WNT (e.g., the 
WNT homepage [49]), and BMP (e.g., WP1425). We include those intracellular molecules that 
we can actually measure in our experiments (see Sections 1.5 and 2.6), and added dashed lines 
to indicate other molecules important for the pathway were omitted (see Section 2.2).
In the WNT pathway, the inhibition of the destruction pathway leads to the inhibition of 
destruction of β-catenin, resulting in its upregulation and nuclear translocation [32]. So the 
net effect of WNT binding to its receptor is the increase of β-catenin activity. To simplify 
the model, we omit the many steps involving the double inhibition mechanisms in the WNT 
pathway, resulting in the simplified path WNT → WNTR → GSK3 → β-catenin → TCF/LEF.
SOX9 regulates expression of the matrix proteins collagen 2 and aggrecan. RUNX2 regu-
lates transcription of collagens I and X and MMP13 [50, 51]. Since the activity of SOX9 and 
RUNX2 is key to the switch from the cartilage to hypertrophic cartilage, we included SOX9 
and RUNX2 and some of their target genes in our diagram (Figure 2, 3A).
2.4. Adding dynamics to the network
Once a priori knowledge network has been chosen, it needs to be drawn in ANIMO as a col-
lection of nodes and interactions. For each node, a maximum number of activity levels can 
be chosen: unless a model is extremely large, it is safe to use 100 levels for all nodes. After 
providing the node with a name and an initial activity (which describes the state of the node 
at the start of a simulation), a description can optionally be added. Descriptions can be used 
as rationale for the presence of a certain node in the model, for example, a node description 
can contain citations to literature or references to own experimental results.
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When adding an interaction between two nodes, a choice for an approximation scenario and 
a k parameter is necessary. The k-constants in our a priori knowledge network are not taken 
from literature as the strength of all interactions is assumed to be equal. This is a pragmatic 
decision, as many actual k-values are not described for most of the protein interactions in our 
network. In our initial models, we assume that there are in general two types of reactions: 
fast reactions for posttranslational modifications, such as phosphorylation, and slow reactions 
where gene transcription occurs. We therefore add reactions between nodes using these two 
types of reaction speed with a “Scenario 1” setting. We also add auto-inhibition to indicate 
inhibition as described in the literature for, e.g., receptor internalization, phosphatase activity, 
and, in the case of NF-κB, nuclear export as regulated by IκB. A more in-depth discussion on 
parameters, scenario choices, and network topology can be found in Refs. [21, 22].
Based on our experience, we expect proteins directly downstream of an activated receptor, 
such as p38 and JNK that are downstream of IL-1R, to be most activated by phosphorylation 
about 15–30 minutes after stimulation, and that the activity would be decreased to the starting 
situation between 60 and 240 minutes after stimulation. We therefore set the initial parameters 
to match these assumptions.
Figure 2. A priori knowledge network of WNT, BMP, and IL-1β pathways. IL-1β canonical (blue) and noncanonical 
signaling (green) showing cross talk with the transcription factors RUNX and SOX9 (both light blue), transcription 
factors from the WNT (red), and BMP2 (purple) pathways. Solid arrows indicate direct protein interaction, and dashed 
arrows indicate that intermediate protein interaction is omitted because no cross talk occurs between these proteins with 
other pathways. The colors indicate the canonical and noncanonical pathways corresponding to the external signals 
WNT, BMP2, and IL-1β.
Protein Phosphorylation164
2.5. Testing network effects of different stimuli in silico
Testing the effect of different stimuli in a computational network is performed in small steps. 
During each step the parameters in the model can be updated so that the dynamics of the vari-
ous nodes in the network match our knowledge.
Step 1. What is the normal “steady-state” (=No Input) situation of the nodes represented in 
the network? For example, for articular chondrocytes it is known that the transcription factor 
SOX9 is active and that collagen 2 and aggrecan are expressed. It is also known that the WNT 
and IL-1β pathways are inactive and that BMP is active at a low level [52, 53]. We therefore 
can adjust our starting activities to these settings. This is generated in Figure 4. We display 
the activities of the proteins of which we plan to measure the phosphorylation, ERK1/2, GSK3, 
JNK, and p38 as well as the gene expression of AXIN2 and COL2A1. Initially, COL2A is 
expressed, indicating SOX9 activity.
Step 2. In a first test of the response of cells to various stimuli, we tested the presence of WNT 
starting from our “steady-state” model generated as described in Step 1. Since we do not 
starve our cells in the experiment, BMP2 is active at a low level of 20 activity units. After WNT 
addition we see that GSK3 becomes activated, and the activity peaks between 30 and 60 min-
utes after WNT addition and then trails off around 400 minutes. We see that AXIN2 becomes 
present between 2 and 4 hours after WNT treatment. This is probably faster than what can be 
expected from a newly synthesized mRNA. At the same time, due to the inactivation of SOX9 
by β-catenin [54], we observe a reduction in the COL2A1 expression around 2–3 hours after 
WNT addition (not shown).
Step 3. We then tested the presence of IL-1β starting from our “steady-state” model. Again, 
BMP is active at a level of 20. We now observe that within 15 minutes of IL-1β addition, 
the three downstream kinases ERK1/2, p38, and JNK become active. In turn, these kinases 
activate RUNX2 [55], thereby activating its target genes. Due to the negative feedback loop 
from RUNX2 to JNK and p38, the activity curve is more narrow for these proteins than it 
is for ERK1/ERK2 [56]. GSK3 becomes slightly active via AKT activation by IL-1β. We see 
no reduction of COL2A mRNA expression and a transient activation of COL1 and COLX 
mRNA expression.
Step 4. Next, we want to see the effect of dual stimulation of WNT and IL-1β when starting 
from a healthy situation as described under Step 1. Addition of WNT and IL-1β, in the pres-
ence of 20% BMP, decreases the activity of SOX9 and therefore causes loss of COL2A1 expres-
sion. At the same time, RUNX2 becomes active, thereby activating MMP13, COL1, and COLX, 
ultimately leading to a hypertrophic phenotype.
Step 5. The next question was what is the effect of IL-1β and WNT in the presence of high 
BMP activity? In our model, the presence of high BMP activity is enough to prevent the loss of 
COL2A expression (not shown), while at the same time leading to induction of RUNX2 activ-
ity and the corresponding COL1 and COLX expression. However, we would have expected 
that the high levels of WNT and IL-1β would lead to reduced SOX9 activity as seen in articles 
describing OA (reviewed in Ref. [31]). We therefore need to adapt our network to match the 
literature data.
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Step 6. It has been described that SOX9 and β-catenin influence each other’s activity [54]. 
Also, RUNX2 suppresses SOX9 in bone formation [57], while SOX9 suppresses RUNX2 activ-
ity [36]. We added mutual inhibitions between SOX9 and RUNX2. This showed that when 
RUNX2 becomes active, it suppresses the SOX9-induced COL2 expression.
These few in silico experiments provide insight into the possible cross talk between these 
three pathways and their effect on SOX9 and RUNX2 activity and the possible effects of 
upstream signals. While asking the questions, we modified the parameters of the reactions, 
added inhibitory loops, and checked signaling cross talk in order to match the reaction speed 
in the model with our literature data or own experience.
This initial model now allows us to investigate the mechanism of IL-1β in inducing cellular 
hypertrophy by directly regulating SOX9 and RUNX2 activity. We hypothesize that IL-1β will 
increase expression of hypertrophic genes by upregulating RUNX2 activity and downregulat-
ing SOX9 activity (Figure 3).
2.6. Testing hypothesis by wet lab experiments
2.6.1. Designing experiment
The outcomes of the in silico experiments are used as guideline for the experimental setup for 
the wet lab validation. In this case, we questioned the effect of IL-1β on WNT signaling in the 
presence or absence of BMP signaling in the cartilage. For this we stimulated cells with IL-1β, 
WNT3A, or BMP2 either alone or in combinations. Parts of the data used in this chapter are 
published previously [21]. The other raw data can be obtained upon request.
2.6.2. Wet lab data
After the creation of the initial model with defined nodes, the next step was to obtain the 
data to fit into the model. This step was carried out mainly with wet lab data complemented 
with literature data. It is important that the analyses of wet lab data show consistency with 
well-known osteoarthritic cellular responses; these analyses are done prior to inclusion of 
experimental data into the model.
Figure 4 shows the measured and predicted activity of the various proteins of our network. 
We observe attenuations in, for example, p38, JNK, and ERK phosphorylation, where WNT 
partially inhibited the effect of IL-β on the phosphorylation of these proteins. We have already 
described these data [21]. When we add BMP to the cells, in combination with IL-1β and 
WNT, we see that in addition to the lower activity of the proteins, there is also a delay in the 
time by which the maximum activity is reached. This results in a delay and a reduction of the 
level of gene expression of all genes tested.
2.6.3. Comparing wet lab data to in silico data
The wet lab data obtained from the experiment were normalized and rescaled from 0 to 100 
in order to be comparable with ANIMO’s simulation results. For the complete  normalization 
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Figure 3. The ANIMO model built to represent the cross talk between the WNT, BMP, and IL-1β pathways. (A) The 
initial configuration of the model. (B) An example of simulation in ANIMO: activity levels of all nodes are shown after 
120 minutes of treatment with WNT + IL-1β using color coding. The node colors are indicative of their activity at the 
indicated time points, with green being most active, via yellow to red, which is inactive as indicated in the figure, bottom 
left.
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procedure, we refer to Ref. [20] and ANIMO’s manual. The resulting.csv tables, together 
with the model, can be found online, in the link below: http://fmt.cs.utwente.nl/tools/animo/
content/models/Phosphorylation.
To evaluate the accuracy of the model, we compared its simulation results against the wet lab 
data concentrating at first on the signal transduction part of the network (Figure 4, first two 
rows). The initial match was already quite close, even if the parameters used in the model were 
all of qualitative nature (Table 1). The heat map graphs we show in Figure 4 were obtained in 
ANIMO, where wet lab data can be directly compared to simulation results.
Another feature provided by ANIMO is parameter fitting, which allows to automatically try 
different parameter values for the interactions in a model, comparing the simulations with a 
given data set. This lets the researcher check whether the model topology can be a plausible 
explanation of the reference wet lab data. In case no parameter set can satisfyingly match the 
given data, or if only a very narrow parameter choice fits well, it is likely necessary to try a 
different wiring of the network model.
2.6.4. Optimizing model
Our next step was to use ANIMO’s automatic parameter fitter on the model, using the wet 
lab data as reference. We divided the model in two subnetworks roughly corresponding to 
Figure 4. Comparing ANIMO’s results with wet lab data: signal transduction. The results from two versions of the 
model are shown: the initial version with qualitative parameters (initial model) and the one obtained with ANIMO’s 
automatic parameter fitting feature (fitted model). Colors are indicative of activity with green being most active and red, 
via yellow, inactive (see Legend).
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Interaction k* Qualitative parameter Scenario k**
ACAN --| ACAN 0.001 Very slow 1 0.001
AKT --> GSK3 0.008 Fast 1 0.01699021
AKT --| AKT 0.004 Medium 1 0.05987754
AXIN2 --| AXIN2 0.002 Slow 1 0.00016882
Beta-catenin --> TCF/LEF 0.008 Fast 1 0.008
Beta-catenin --| beta-catenin 0.002 Slow 1 0.002
Beta-catenin --| NF-κB 0.008 Fast 1 0.03027397
Beta-catenin --| SOX9 0.016 Very fast 1 0.01824899
BMP2 --> BMPRI/BMPRII 0.016 Very fast 1 0.01769909
BMPR internalization --| BMPRI/
BMPRII
0.016 Very fast 2 0.01426827
BMPRI/BMPRII --> BMPR 
internalization
0.001 Very slow 1 0.00067129
BMPRI/BMPRII --> SMAD1/5/8 0.008 Fast 1 0.00804472
COL1 --| COL1 0.002 Slow 1 0.002
COL2A --| COL2A 0.001 Very slow 1 0.00042541
COLX --| COLX 0.002 Slow 1 0.002
ERK1/ERK2 --> RUNX2 0.004 Medium 1 0.00417643
ERK1/ERK2 --| ERK1/ERK2 0.004 Medium 1 0.0112296
GSK3 --> beta-catenin 0.016 Very fast 1 0.01599999
GSK3 --> GSK3 phosphatase 0.008 Fast 1 0.02126481
GSK3 phosphatase --| GSK3 0.016 Very fast 2 0.03690672
ID1 --| ID1 0.002 Slow 1 0.00127961
IkB --| NF-κB 0.002 Slow 1 0.00223597
IL-1B --> IL-1RI 0.008 Fast 1 0.01240816
IL1B --| IL-1B 0.002 Slow 1 0.00060578
IL-1BR internalization --| IL-1RI 0.032 Very fast + 2 0.03583533
IL-1RI --> AKT 0.004 Medium 1 0.04684802
IL-1RI --> beta-catenin 0.008 Fast 1 0.00908979
IL-1RI --> ERK1/2 0.008 Fast 1 0.0041156
IL-1RI --> IL-1BR internalization 0.004 Medium 1 0.00782616
IL-1RI --> JNK 0.008 Fast 1 0.016
IL-1RI --> NF-κB 0.016 Very fast 1 0.04698054
IL- 1RI --> p38 0.008 Fast 1 0.04107936
JNK --> RUNX2 0.004 Medium 1 0.00414343
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Interaction k* Qualitative parameter Scenario k**
JNK --| JNK 0.004 Medium 1 0.00055435
MMP13 --| MMP13 0.002 Slow 1 0.002
NF-κB --> IkB 0.016 Very fast 1 0.016
NF-κB --> IL-1B 0.002 Slow 1 0.00156559
NF-κB --> MMP13 0.001 Very slow 1 0.001
p38 --> RUNX2 0.004 Medium 1 0.00399137
p38 --| p38 0.004 Medium 1 0.04260553
RUNX2 --> COL1 0.002 Slow 1 0.002
RUNX2 --> COLX 0.002 Slow 1 0.002
RUNX2 --> MMP13 0.001 Very slow 1 0.001
RUNX2 --| JNK 0.004 Medium 1 0.00606149
RUNX2 --| p38 0.004 Medium 1 0.00406615
RUNX2 --| RUNX2 0.004 Medium 1 0.01181898
RUNX2 --| SOX9 0.004 Medium 1 0.004
SMAD1/5/8 --> ID1 0.002 Slow 1 0.00270426
SMAD1/5/8 --> RUNX2 0.008 Fast 1 0.008
SMAD1/5/8 --> SMAD7 0.004 Medium 1 0.00671529
SMAD1/5/8 --> SOX9 0.004 Medium 1 0.004
SMAD7 --| SMAD1/5/8 0.008 Fast 2 0.02130379
SOX9 --> ACAN 0.001 Very slow 1 0.001
SOX9 --> COL2A 0.001 Very slow 1 0.001
SOX9 --| beta-catenin 0.001 Very slow 1 0.00028855
SOX9 --| RUNX2 0.004 Medium 1 8.7016E-05
SOX9 --| SOX9 0.002 Slow 1 0.00424899
SOX9-activating signal --> SOX9 0.016 Very fast 1 0.00255911
TCF/LEF --> AXIN2 0.001 Very slow 1 0.00021457
TCF/LEF --| TCF/LEF 0.004 Medium 1 0.004
WNT --> WNTR 0.008 Fast 1 0.02304019
WNTR --> AKT 0.016 Very fast 1 0.04626554
WNTR --> GSK3 0.008 Fast 1 0.00372738
WNTR --> WNTR internalization 0.004 Medium 1 0.00600663
WNTR internalization --| WNTR 0.016 Very fast 1 0.06497972
Table 1. Parameters for WNT, BMP, and IL-1β signaling in the initial model (k*) and the fitted model that was optimized 
using experimental data (k**; see Section 2.6.4).
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the WNT and IL-1 pathways. The two subnetworks were independently fit, based on the wet 
lab data for the treatments with WNT and IL-1. Dividing the model allowed us to limit the 
parameter space for the automatic search, making it more rapid: it took less than 3 minutes to 
complete. In practice, to fit a part of the ANIMO model, we disabled the part of the network 
we were not focusing on. We then selected those interactions whose parameters we wanted 
to optimize and clicked on the “Optimize k-Values” command in ANIMO’s interface. After 
providing the proper file with the wet lab data, we let the tool to automatically try different 
k-values for the interactions, comparing the model simulations with the data and determining 
the fitness. Once the tool could find a better fitting set of parameters, the process would ter-
minate, showing the resulting match for the candidate parameter set. We repeated the same 
procedure on both WNT and IL-1 pathways, fitting the signal transduction parts to the data. 
We then simulated the WNT + IL-1 treatment in the model and compared it to the data, find-
ing it was fitting already well enough (see Figure 4, first and last row).
For BMP2 signaling we optimized SMAD activity based on phosphorylation of Western blot 
of SMAD1/5/8. SMAD1/5/8 was most active at 15 minutes posttreatment (data not shown).
Finally, we compared the model with the polymerase chain reaction (PCR) experimental data, 
repeating the fitting process only on that part of the network. The resulting model parameters 
can be found in Table 1 (k**), while the comparison between PCR data and ANIMO mRNA 
node activities is shown in Figure 5. We note that the general trends were captured in the model. 
Differences between activities in the model vs. the experimental data are especially visible in the 
longer time scales, around 24 hours. This can be expected because higher order effects, such as 
feedback loops, which take place on longer time scales, are not included in our model.
Figure 5. Comparing ANIMO’s results with wet lab data: protein production. The activities of nodes representing 
mRNA in the ANIMO model (bottom panel) were compared against wet lab PCR data for actin, Col2a, ID1, and IL-1 
(top panels).
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Figure 6. In silico validation of hypothesis: IL-1β will increase expression of hypertrophic genes, COL1, COL10, and 
MMP13, by upregulating RUNX2 activity and downregulating SOX9 activity.
2.6.5. Validating hypothesis
Our hypothesis that IL-1β will increase expression of hypertrophic genes by upregulating 
RUNX2 activity and downregulating SOX9 activity can now be tested in our optimized 
model. For this, we can investigate, in silico, the changes in activity of SOX9 and RUNX2 and 
their corresponding genes, even when no gene expression is measured in the wet lab.
Our model predicts that in the presence of IL-1β and WNT, SOX9 activity will be inhibited 
and RUNX2 will be activated with an initial peak activity in the first hour (Figure 6). This indi-
cates loss of cartilage homeostasis and a slight increase in hypertrophy, which is sustained 
in time due to the permanent increase in RUNX2 activity (not shown). So even though the 
initial WNT and IL-1 signal are no longer present, an increase in RUNX2 activity results in 
a sustained expression of collagen 1 and collagen 10 as well as MMP13, albeit at a low level. 
Even high levels of BMP2 cannot prevent the loss of SOX9 activity, eventually leading to 
hypertrophy. These data validate our hypothesis, at least in silico.
3. Discussion and conclusion
In this chapter we provide an example of a workflow for starting computational modeling 
based on literature and experimental data. The aim was not to make the most comprehensive 
model in terms of network topology, but to understand the dynamics of the network activity 
in terms of signaling cross talk and corresponding downstream effects.
We chose to use the software ANIMO as a plug-in in Cytoscape as it offers a user-friendly 
interface in which biologists can interactively create and explore computational models of 
signal transduction networks. This allows to gain intellectual control over the dynamic behav-
ior of the network that is modeled. We showed that network topologies can be constructed, 
modified, and enhanced with a formal description of the associated dynamic behavior. The 
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process of modeling biological network dynamics is a prerequisite for formally comparing 
experimental data to a priori knowledge. ANIMO can also be used in research groups to assist 
in the storage and transfer of knowledge on biological networks and as a guide in discussions.
Most of the plug-ins for Cytoscape are based on static analyses, for example, they make it 
possible to find the hubs in a network, to cluster nodes by specific features, or to associate 
external data sources to the network. This allows to effectively represent large quantities of 
information and obtain useful insight from them, but the focus is still on the “static picture.” 
ANIMO concentrates instead on the network dynamics: applying an abstract representation 
of biochemical kinetics, it allows to represent how signaling networks evolve with time under 
different conditions. Graphs and node colors provide the user with useful representations 
of the network dynamics. Further analyses are enabled by the possibility to perform model 
checking on the underlying timed automata model, which can be used without the need to 
acquire additional training in formal methods.
ANIMO describes biological entities in the network in terms of their activity. This general-
izes easily into most signal transduction processes. However, this can also be used to model 
any process that can be abstractly modeled as a variable activity. Examples are the inclusion 
of processes such as receptor internalization and phosphatase activity but also inhibition of 
an activated protein by proteosomal degradation or nuclear export. This flexibility helps the 
user in describing parts of the network for which the molecular details are unknown or of 
lesser importance.
In the model presented here, we show how a priori knowledge network based on three sig-
naling pathways can be constructed and tested in silico by asking questions in small steps at 
a time. We then showed how experimental data of a limited number of proteins and genes, 
at a wide range of time points, aid to optimize topology and dynamics of the proteins and 
mRNAs in our network. In the next step, we can prioritize and design new experiments that 
can be validated in the wet lab. Seeing the role of a computational model in the empirical 
spiral in Figure 1, the work is never finished, but each step in the cycle aids to optimize the 
model and hence the molecular insight into the dynamics and topology of the cellular signal 
transduction network.
In ANIMO we proved our hypothesis that IL-1β will increase expression of hypertrophic 
genes by upregulating RUNX2 activity and downregulating SOX9 activity. For this we used 
a combination of literature and experimental data to optimize the model parameters. This 
allowed us to obtain insight into the order of events in the presence of WNT and/or IL-1β at 
the level of SOX9 and RUNX2 activity. In addition, it allowed insight into the complex inter-
connectivity of three individual pathways. Such models also yield high content data at high 
temporal resolution, a feat that is difficult to achieve using only wet lab approaches.
Interestingly, in one computational model, we are able to show a combination of protein 
activity (phosphorylation) and subsequent mRNA expression. This is a combination model of 
events at very different time lines. The advantage of our strategy, which included automatic 
parameter fitting, is the possibility to predict cell fate based on both changes in phosphoryla-
tion/protein activity and corresponding gene expression differences.
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In the future, ANIMO and related tools may lead to a new paradigm for interactive rep-
resentation of biological networks. Networks in digital textbooks and articles could be 
displayed as animations amenable to modifications by readers. Repositories of formal 
descriptions of signaling modules could be used to put together executable signaling net-
works. A more user-friendly way of interacting with dynamic network models will lead 
to a more thorough understanding of biological networks and will accelerate hypothesis-
driven research.
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